What are the different classes of antihypertensive medications, their mechanisms of action, examples of drugs, safety during pregnancy, and contraindications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antihypertensive Medication Classes: Mechanisms, Examples, Pregnancy Safety, and Contraindications

1. Thiazide and Thiazide-Like Diuretics

Mechanism of Action:

  • Promote sodium and water excretion by inhibiting sodium-chloride cotransporter in the distal convoluted tubule, leading to decreased intravascular volume 1
  • Act as indirect vasodilators by depleting salt and water within the intramural portion of arterioles, diminishing responsiveness to catecholamines and angiotensin II 2

Examples:

  • Hydrochlorothiazide 1
  • Chlorthalidone 1

Pregnancy Safety:

  • NOT recommended during pregnancy 1, 3
  • May reduce normal plasma volume expansion and compromise uteroplacental perfusion 3
  • Chronic use associated with restricted maternal plasma volume and reduced uteroplacental perfusion 1
  • May increase risk of pre-eclampsia 3

Contraindications:

  • Severe renal impairment/anuria 1
  • Hypokalemia or hyponatremia 1

2. ACE Inhibitors (Angiotensin-Converting Enzyme Inhibitors)

Mechanism of Action:

  • Inhibit conversion of angiotensin I to angiotensin II, decreasing vasoconstriction and aldosterone production 2
  • Reduce both preload and afterload through vasodilation 4

Examples:

  • Lisinopril 4
  • Enalapril 1

Pregnancy Safety:

  • CONTRAINDICATED during pregnancy 1, 5
  • May cause fetal renal dysplasia, oligohydramnios, intrauterine growth restriction, and fetal death 1
  • Women who become pregnant must be transitioned immediately to safe alternatives 1

Contraindications:

  • Pregnancy (all trimesters) 1, 4
  • History of angioedema with prior ACE inhibitor use 4

3. Angiotensin II Receptor Blockers (ARBs)

Mechanism of Action:

  • Block angiotensin II at AT1 receptors, preventing vasoconstriction and aldosterone secretion 6
  • Provide similar hemodynamic effects to ACE inhibitors without affecting bradykinin metabolism 6

Examples:

  • Valsartan 6
  • Losartan 7

Pregnancy Safety:

  • CONTRAINDICATED during pregnancy 1, 5
  • Cause severe fetotoxicity including renal dysplasia and fetal death 8
  • Must be discontinued immediately upon pregnancy recognition 1

Contraindications:

  • Pregnancy (all trimesters) 1, 6
  • Concomitant use with ACE inhibitors or renin inhibitors (increases cardiovascular and renal risk) 1

4. Calcium Channel Blockers (CCBs)

Mechanism of Action:

  • Block L-type calcium channels in vascular smooth muscle and cardiac tissue, causing vasodilation and reduced peripheral resistance 9
  • Dihydropyridines (e.g., nifedipine) are more selective for vascular smooth muscle 10

Examples:

  • Nifedipine (dihydropyridine) 8
  • Amlodipine (dihydropyridine) 1

Pregnancy Safety:

  • SAFE for use during pregnancy 1, 8
  • Extended-release nifedipine is a first-line option for hypertension in pregnancy 8
  • Caution: Avoid concurrent use with magnesium sulfate due to risk of precipitous blood pressure drop 5

Contraindications:

  • Severe aortic stenosis (for dihydropyridines) 1
  • Acute myocardial infarction with pulmonary congestion 1

5. Beta-Blockers

Mechanism of Action:

  • Block beta-adrenergic receptors, decreasing cardiac output, heart rate, and renin release 2
  • Inhibit prejunctional release of norepinephrine and may have central nervous system effects 2

Examples:

  • Atenolol 11
  • Labetalol (combined alpha/beta-blocker) 5

Pregnancy Safety:

  • Labetalol is SAFE and preferred during pregnancy 1, 5, 8
  • Atenolol should be avoided due to association with intrauterine growth restriction 1
  • Labetalol has efficacy comparable to methyldopa with fewer side effects 5

Contraindications:

  • Severe bradycardia or heart block (second or third degree) 11
  • Decompensated heart failure 11

6. Aldosterone Antagonists (Potassium-Sparing Diuretics)

Mechanism of Action:

  • Block aldosterone receptors in the distal tubule and collecting duct, promoting sodium excretion while retaining potassium 1
  • Reduce sodium reabsorption without causing hypokalemia 1

Examples:

  • Spironolactone 1
  • Eplerenone 1

Pregnancy Safety:

  • Limited safety data; generally avoided during pregnancy 1
  • Not recommended as first-line agents in pregnancy due to insufficient evidence 3

Contraindications:

  • Hyperkalemia 1
  • Significant renal dysfunction (risk of hyperkalemia) 1

7. Alpha-1 Adrenergic Blockers

Mechanism of Action:

  • Block alpha-1 receptors on vascular smooth muscle, causing vasodilation and reduced peripheral resistance 2
  • Decrease blood pressure without reflex tachycardia 9

Examples:

  • Prazosin 1
  • Doxazosin 1

Pregnancy Safety:

  • SAFE for use during pregnancy 1
  • Prazosin is listed as an effective and safe option in pregnancy 1

Contraindications:

  • Orthostatic hypotension 1
  • Severe hepatic impairment 1

8. Centrally Acting Agents

Mechanism of Action:

  • Act on central alpha-2 receptors in the brainstem, decreasing sympathetic outflow from the vasomotor center 2
  • Reduce peripheral vascular resistance and heart rate 2

Examples:

  • Methyldopa 1, 5
  • Clonidine 1, 8

Pregnancy Safety:

  • SAFE and PREFERRED during pregnancy 1, 5, 8
  • Methyldopa has the longest safety record and is considered first-line 5
  • Clonidine is also safe and effective 1, 8

Contraindications:

  • Active hepatic disease (for methyldopa) 1
  • Severe coronary insufficiency 2

Key Clinical Considerations

Primary Agents for General Hypertension: The ACC/AHA guidelines identify thiazide diuretics, ACE inhibitors, ARBs, and CCBs as primary agents with proven reduction in clinical events 1. Beta-blockers lack adequate evidence for initial use in uncomplicated hypertension 1.

Pregnancy-Safe Algorithm: For hypertensive pregnant women, the treatment hierarchy is: 1) Methyldopa or labetalol as first-line; 2) Nifedipine (extended-release) as second-line; 3) Avoid ACE inhibitors, ARBs, and diuretics unless specific indications exist 8, 5, 1.

Critical Pitfall: Simultaneous use of ACE inhibitors with ARBs or renin inhibitors is potentially harmful and increases cardiovascular and renal risk 1. This combination should never be used 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The clinical pharmacology of antihypertensive drugs.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1984

Guideline

Diuretics in Pregnancy: Safety Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pregnancy-Induced Hypertension Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Are there benefits to specific antihypertensive drug therapy?

American journal of hypertension, 2003

Guideline

Management of Hypertension in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antihypertensive drugs.

Pharmacological research, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.